12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 23.6% to $0.28 during Thursday’s after-market session. At the close, Bluejay…
Benzinga’s Top Ratings Upgrades, Downgrades For May 18, 2023
Upgrades According to CIBC, the prior rating for BlackBerry Ltd (NYSE:BB) was changed from Underperformer to Neutral. In…
Tesla, Manchester United, Ohmyhome, Target, Coya: Why These 5 Stocks Are Drawing Investor Attention Today
U.S. markets ended in the red on Tuesday as a barrage of factors including the yet inconclusive debt…
Why Coya Therapeutics Shares Are Shooting Higher Today
Coya Therapeutics Inc (NASDAQ: COYA) reported results from an open-label proof-of-concept clinical study for COYA 301 in
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 27.6% to $4.3 during Tuesday’s pre-market session. The company’s market cap…
Coya Therapeutics Highlights Presentation Of Results From Open-Label Proof-Of-Concept Study Of COYA 301; Says ‘Treatment with COYA 301 resulted in a statistically significant improvement in cognitive function’
The open-label study evaluated the safety and tolerability, biological activity, blood biomarkers and preliminary efficacy of COYA 301 in 8 patients with Alzheimer's disease (AD). The investigator-initiated study
Benzinga’s Top Ratings Upgrades, Downgrades For May 3, 2023
Upgrades For The Trade Desk Inc (NASDAQ:TTD), Vertical Research upgraded the previous rating of Neutral to Positive. Trade…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 184.3% to $1.0 during Thursday’s regular session. As of 13:30 EST,…
Chardan Capital Initiates Coverage On Coya Therapeutics with Buy Rating, Announces Price Target of $9
Chardan Capital analyst Keay Nakae initiates coverage on Coya Therapeutics (NASDAQ:COYA) with a Buy rating and announces Price Target of $9.